THE USE OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN COMPARING CHORIOCAPILLARIS RECOVERY BETWEEN TWO TREATMENT STRATEGIES FOR MULTIFOCAL CHOROIDITIS - NI

PGIMER0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients (between 19-60 years of age, either gender) with the following inclusion criteria were enrolled in the study:
•1. Subjects diagnosed with active multifocal lesions of choroiditis in at least one eye involving the posterior pole. Subjects with diagnosis of either autoimmune multifocal choroiditis or TB SLC will be included in the study.
•2. The disease activity confirmed on clinical examination, and imaging techniques such as optical coherence tomography, fundus autofluorescence, fluorescein angiography, and indocyanine green angiography.
•3. Subjects who are treatment-naÃ¯ve or those who develop active disease with <=10mg/day oral corticosteroids.

•Eyes in which media clarity was obscured by the presence of cataract, vitritis or any other such coexistent pathology that does not allow the acquisition of good images.
•Subjects with active lesions outside the posterior pole that is no amenable to fundus imaging.
•Subjects on treatment with long-term systemic immunosuppressive therapies, or those who have received intravitreal treatments in the past. In addition, subjects who have undergone pars plana vitrectomy (at any time point), cataract surgery (within the last 3 months), or glaucoma surgery (within the last 3 months) will be excluded.
•Subjects who are pregnant or plan to become pregnant during the course of therapy.
•Subjects with placoid choroiditis characterized by large, plaque-like lesions involving large areas of the retinochoroid.
•Subjects with concomitant ocular diseases such as diabetic retinopathy, optic neuropathy, or retinal degeneration.
•Patients who do not agree to come for follow-up visits.

发起方